le 9 mars/March&nbsp;2022

	The common shares of Albert Labs International Corp., previously listed&nbsp;as ME Resource Corp., (MEC) have been approved for listing on the CSE.

	Listing and disclosure documents will be available at&nbsp;<a href="https://www.thecse.com/en/listings/life-sciences/albert-labs-international-corp">www.thecse.com</a>&nbsp;on the trading date.

	Albert Labs International Corp., is a&nbsp;laboratory-based, clinical research and drug development enterprise addressing mental health care needs. Through a succinct clinical pathway, focusing on Real World Evidence (RWE) Albert Labs look to commercialize its psychedelic-based treatments, and in doing so deliver psychedelic-assisted psychotherapy to patients sooner. Focused on accelerating access and faster approvals, Albert Labs put patients with urgent and unmet needs first as it develops licensed medicines to treat a variety of mental health conditions. Cancer-related distress, an initial focus of Albert Labs development program is thought to affect over 16 million patients worldwide.

	____________________

	Les actions ordinaires d'Albert Labs International Corp., précédemment cotées sous le nom de ME Resource Corp., (MEC) ont été approuvées pour être cotées sur le CSE.

	Les documents d'inscription et d'information seront disponibles sur <a href="https://www.thecse.com/fr/inscriptions/sciences-biologiques/albert-labs-international-corp">www.thecse.com</a> à la date de négociation.

	Albert Labs International Corp. est une entreprise de recherche clinique et de développement de médicaments en laboratoire qui répond aux besoins en matière de soins de santé mentale. Grâce à un parcours clinique succinct, axé sur les preuves du monde réel (RWE), Albert Labs cherche à commercialiser ses traitements à base de psychédéliques et, ce faisant, à proposer plus tôt une psychothérapie assistée par psychédélique aux patients. Axé sur l'accélération de l'accès et des approbations plus rapides, Albert Labs donne la priorité aux patients ayant des besoins urgents et non satisfaits en développant des médicaments sous licence pour traiter une variété de problèmes de santé mentale. La détresse liée au cancer, un objectif initial du programme de développement d'Albert Labs, toucherait plus de 16 millions de patients dans le monde.
<table border="1" cellpadding="0" cellspacing="0" >
<tbody>
<tr>
<td >

					Issuer/Émetteur:
</td>
<td >

					Albert Labs International Corp.
</td>
</tr>
<tr>
<td >

					Security Type/Titre:
</td>
<td >

					Common&nbsp;Shares/Actions&nbsp;ordinaires
</td>
</tr>
<tr>
<td >

					Symbol(s)/Symbole(s):
</td>
<td >

					ABRT
</td>
</tr>
<tr>
<td >

					Number of securities issued and outstanding/&nbsp;Titres&nbsp;émis&nbsp;et en circulation:
</td>
<td >

					67 280 035
</td>
</tr>
<tr>
<td >

					Number of Securities reserved for issuance/&nbsp;Titres&nbsp;réservés&nbsp;pour&nbsp;émission:
</td>
<td >

					0
</td>
</tr>
<tr>
<td >

					CSE Sector/Catégorie:
</td>
<td >

					Life Sciences/sciences biologiques
</td>
</tr>
<tr>
<td >

					CUSIP:
</td>
<td >

					012784 10 4
</td>
</tr>
<tr>
<td >

					ISIN:
</td>
<td >

					CA 012784 10 4 1
</td>
</tr>
<tr>
<td >

					OLD&nbsp;CUSIP/ISIN:
</td>
<td >

					552749103/5527491032
</td>
</tr>
<tr>
<td >

					Boardlot/Quotité:
</td>
<td >

					500
</td>
</tr>
<tr>
<td >
				Consolidation:</td>
<td >
				10 Old for 1 New/10 Ancien&nbsp;pour 1 Nouveaux</td>
</tr>
<tr>
<td >

					Trading&nbsp;Currency/Monnaie&nbsp;de&nbsp;négociation:
</td>
<td >

					CDN$/$CDN
</td>
</tr>
<tr>
<td >

					Trading Date/Date de&nbsp;negociation:
</td>
<td >

					Le 10 mars/March 2022
</td>
</tr>
<tr>
<td >

					Other Exchanges/Autres&nbsp;marches:
</td>
<td >

					N/A
</td>
</tr>
<tr>
<td >

					Fiscal Year&nbsp;end /Clôture&nbsp;de&nbsp;l'exercice&nbsp;financier:
</td>
<td >

					le 31&nbsp;décembre/December
</td>
</tr>
<tr>
<td >

					Transfer Agent/Agent des&nbsp;transferts:
</td>
<td >

					Computershare Investor Services Inc.
</td>
</tr>
</tbody>
</table>

	The Exchange is accepting Market Maker applications for ABRT. Please email:&nbsp;<a href="mailto:Trading@theCSE.com">Trading@theCSE.com</a>

	If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail:&nbsp;<a href="mailto:Listings@thecse.com">Listings@thecse.com</a>

	Pour&nbsp;toute&nbsp;question, pour&nbsp;obtenir&nbsp;de&nbsp;l’information&nbsp;supplémentaire&nbsp;veuillez&nbsp;communiquer&nbsp;avec&nbsp;le service des inscriptions au 416 367-7340 ou par&nbsp;courriel&nbsp;à&nbsp;l’adresse:&nbsp;&nbsp;<a href="mailto:Listings@thecse.com">Listings@thecse.com</a>

Albert Labs International Corp.

2022-0312 - Fundamental Change - ME Resource Corp./Albert Labs International Corp.

CSE25™

CSE Composite Index®

In this series, we delve deep into the experiences of CSE listed companies, exploring their past successes and future opportunities.

CSE Issuer Spotlight

**Follow us** for the **latest news** from the CSE

 The CSE provides a modern and efficient alternative for companies looking to access the Canadian public capital markets.

The Canadian Securities Exchange (CSE)

Learn how we streamline issuer regulation through enhanced disclosure, practical and effective regulatory oversight, and modern technology.

Listing on the CSE

Learn more about the companies we list and how to get started trading on the CSE.

Investing in Listed Companies

Learn how we lower costs, reduce complexity, and provide market making opportunities for the dealer community.

Trading on the CSE

Whether you’re an investor, business leader, or simply looking to learn more, start your journey with the CSE here.

Get Started

From announcements and market updates to in-depth interviews with company leaders - stay informed with the latest from the CSE.

Latest from the CSE

Discover newly listed companies on the CSE through our series of bite-sized interviews with company leaders.

Get to know our latest listings

Listed Company News

Market Activity

List with the CSE

Find a home for your next big idea.

Frequently Asked Questions

How does being listed on the CSE affect me as a shareholder?

Where do I get information and trade CSE listed securities?

Where can I find an RSS feed for listed company news?

Where is the CSE recognized?

Upcoming Events

join the list

Join our mailing list to receive buy-in notifications

The CSE provides a superior exchange experience by investing in our customers’ success with innovation, dedication, and passion.

Where innovation, passion, and trust intersect

We strive to be the most innovative exchange in Canada. We aim to offer unlimited global access and a customized client-centric experience while delivering the lowest cost of public capital. 

We are Canada's entrepreneurial exchange

The most searched CSE listed companies on thecse.com

Recent Quotes

Get the latest regulatory announcements from the CSE concerning its Listings Policies, Trading Rules and functionality and other important industry developments.

Notices

Get the latest information about new CSE listings, the appointment of Market Makers, market events, and other news.

Bulletins

Stay informed with CSE listed company news, providing transparency and accountability to shareholders and the public.

Company News

Stay Informed

The **total volume** traded on the CSE today is

Connect with our professionals and listing experts at industry events and conferences.